Seiichi Imanishi
Sakai, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Age-dependent relative and absolute benefit of radiotherapy after breast-conserving surgery: a population-based analysis using SEER data.
Journal: Breast cancer research and treatment
Published: May 04, 2026
Validation of the predictive ability for recurrence and the clinical utility of the 95-gene classifier (95GC) through an integrated analysis of five studies.
Journal: Breast cancer (Tokyo, Japan)
Published: March 24, 2025
Successful BRCA2 Mutation Detection via Tissue-Based Gene Panel Testing in Post-bone Marrow Transplant Breast Cancer: Implications for Precision Medicine.
Journal: Cureus
Published: February 08, 2025
Possibility of Human Epidermal Growth Factor Receptor 2 Expression as a Treatment Selection Indicator in Early Triple-Negative Breast Cancer.
Journal: Cureus
Published: November 26, 2024
Validation of the prognosis of patients with ER‑positive, HER2‑negative and node‑negative invasive breast cancer classified as low risk by Curebest™ 95GC Breast in a multi‑institutional registry study.
Journal: Oncology letters
Published: October 30, 2022
Significance of the effects of chemotherapy on programmed death-ligand 1 expression in triple-negative breast cancer.
Journal: Japanese journal of clinical oncology
Published: March 18, 2022
Tumor-derived interleukin-34 creates an immunosuppressive and chemoresistant tumor microenvironment by modulating myeloid-derived suppressor cells in triple-negative breast cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: January 12, 2022
Clinicopathological analysis of homologous recombination-deficient breast cancers with special reference to response to neoadjuvant paclitaxel followed by FEC.
Journal: Breast cancer research and treatment
Published: September 16, 2018
Docetaxel, cyclophosphamide, and trastuzumab as neoadjuvant chemotherapy for HER2-positive primary breast cancer.
Journal: Breast cancer (Tokyo, Japan)
Published: October 01, 2015
Analysis of the Side Effects of Docetaxel with Cyclophosphamide (TC Therapy)
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: July 23, 2015
Docetaxel and cyclophosphamide as neoadjuvant chemotherapy in HER2-negative primary breast cancer.
Journal: Breast cancer (Tokyo, Japan)
Published: July 07, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026